Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

Clinical trial NCT07327840 · RECRUITING

Trial details

NCT number: NCT07327840
Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lipoprotein Disorder

Start date: 2025-10-29
Primary completion: 2027-02-28
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.